Reasoning of an anomaly: Residual block after sugammadex

Anesthesia and Analgesia

Volumn 117, Issue 2, 2013, Pages 297-300

  Naguib, Mohamed ^a   Brull, Sorin J ^b   Arkes, Hal R ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MAYO CLINIC   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; NEOSTIGMINE; PROPOFOL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; VECURONIUM;

ACCELEROMETER; ACCELEROMETRY; ACCELEROMYOGRAPHY; ANESTHESIST; ANESTHETIC RECOVERY; CLINICAL EXAMINATION; COST; DRUG COST; HUMAN; METHODOLOGY; MONITOR; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOGRAPHY; NERVE STIMULATOR; NEUROMUSCULAR BLOCKING; PATIENT MONITORING; PHYSICIAN ATTITUDE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECOVERY ROOM; REVIEW;

ANDROSTANOLS; CHOLINESTERASE INHIBITORS; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MUSCLE WEAKNESS; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR MONITORING; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 84881351532     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0b013e318292ee3c     Document Type: Review

References (28)

1. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscu-lar block. Anesth Analg 2013;117:345-51
2. Beemer GH, Rozental P. Postoperative neuromuscular function. Anaesth Intensive Care 1986;14:41-5
3. Heier T, Caldwell JE, Feiner JR, Liu L, Ward T, Wright PM. Relationship between normalized adductor pollicis train-of-four ratio and manifestations of residual neuromuscular block: a study using acceleromyography during near steady-state concentrations of mivacurium. Anesthesiology 2010;113:825-32
4. Brull SJ. Indicators of recovery of neuromuscular function: time for change? Anesthesiology 1997;86:755-7
5. McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, Monk TG. Effcacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromus-cular blockade in elderly patients. Anesthesiology 2011;114:318-29
6. Videira RL, Vieira JE. What rules of thumb do clinicians use to decide whether to antagonize nondepolarizing neuromuscular blocking drugs? Anesth Analg 2011;113:1192-6
7. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ. A survey of current management of neuromuscular block in the United States and Europe. Anesth Analg 2010;111:110-9
8. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008;107:130-7
9. Brull SJ, Naguib M, Miller RD. Residual neuromuscular block: rediscovering the obvious. Anesth Analg 2008;107:11-4
10. Kopman AF. Managing neuromuscular block: where are the guidelines? Anesth Analg 2010;111:9-10
11. Futter M, Gin T. Neuromuscular block: views from the Western pacifc. Anesth Analg 2010;111:11-2
12. Miller RD, Ward TA. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine. Anesth Analg 2010;111:3-5
13. Donati F. Neuromuscular monitoring: what evidence do we need to be convinced? Anesth Analg 2010;111:6-8
14. Viby-Mogensen J, Jørgensen BC, Ording H. Residual curariza-tion in the recovery room. Anesthesiology 1979;50:539-41
15. Fawcett WJ, Dash A, Francis GA, Liban JB, Cashman JN. Recovery from neuromuscular blockade: residual curarisation following atracurium or vecuronium by bolus dosing or infusions. Acta Anaesthesiol Scand 1995;39:288-93
16. Kopman AF, Yee PS, Neuman GG. Relationship of the train-of-four fade ratio to clinical signs and symptoms of residual paralysis in awake volunteers. Anesthesiology 1997;86:765-71
17. Naguib M, Kopman AF, Ensor JE. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. Br J Anaesth 2007;98:302-16
18. Bevan DR, Kahwaji R, Ansermino JM, Reimer E, Smith MF, O'Connor GA, Bevan JC. Residual block after mivacurium with or without edrophonium reversal in adults and children. Anesthesiology 1996;84:362-7
19. Naguib M, Brull SJ. Sugammadex: a novel selective relaxant binding agent. Expert Rev Clin Pharmacol 2009;2:37-53
20. Bridion (Sugammadex) data sheet. Available at: http://www. shijieyaofang.com/upload/product/201252101102810.pdf. Accessed September 10, 2012
21. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg 2010;111:129-40
22. Thilen SR, Hansen BE, Ramaiah R, Kent CD, Treggiari MM, Bhananker SM. Intraoperative neuromuscular monitoring site and residual paralysis. Anesthesiology 2012;117:964-72
23. Dawson NV, Connors AF Jr, Speroff T, Kemka A, Shaw P, Arkes HR. Hemodynamic assessment in managing the critically ill: is physician confdence warranted? Med Decis Making 1993;13:258-66
24. Kahneman D. Don't Blink! The Hazards of Confdence. New York Times Magazine October 19, 2011 Available at: http://www.nytimes.com/2011/10/23/ magazine/dont-blink-the-hazards-of-confdence.html. Accessed April 20, 2013
25. Slovic P, Fischhoff B, Lichtenstein S. Accident probabilities and seat belt usage: a psychological perspective. Accid Anal & Prev 1978;10:281-5
26. Merenstein D. A piece of my mind. Winners and losers. JAMA 2004;291:15-6
27. Aberegg SK, Arkes H, Terry PB. Failure to adopt benefcial therapies caused by bias in medical evidence evaluation. Med Decis Making 2006;26:575-82
28. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 1979;47:263-91